Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Healthcare Triangle, Inc. (HCTI)
USD1.78
+0.04 (+2.05%)
US NASDAQ Healthcare Medical - Healthcare Information Services
Address
4309 Hacienda Drive 94588
Pleasanton, CA, US
Pleasanton, CA, US
CEO
Lakshmanan Kannappan
Website
healthcaretriangle.com
IPO
2021-10-13
CIK 1839285 ISIN US42227W4050
Description
Healthcare Triangle, Inc. (HCTI) is a technology firm dedicated to the healthcare sector, specializing in crafting innovative solutions across cloud services, data science, and professional and managed IT support. The company provides a comprehensive array of software, platforms, and services designed to empower healthcare and pharmaceutical organizations. These offerings help facilitate personalized treatment plans, accelerate precision medicine initiatives, drive innovation in drug discovery and development, foster collaborative research efforts, enable evidence-based decision-making, and streamline digital transformation. Among its proprietary software offerings are CloudEz, an enterprise platform streamlining multi-cloud migration and oversight, allowing clients to unify management of their private, hybrid, and public cloud environments. Another key platform is DataEz, a cloud-native solution providing robust data analytics and scientific data processing capabilities tailored for the life sciences, pharmaceutical, and healthcare provider sectors. Additionally, the company offers Readabl.AI, a Software-as-a-Service (SaaS) solution leveraging public cloud-based artificial intelligence and machine learning to intelligently identify and extract vital healthcare data from diverse documents such as faxes and narrative reports. Beyond its platforms, Healthcare Triangle delivers a range of cloud-centric IT services and specialized healthcare IT support. This includes the implementation, optimization, and integration of electronic health records (EHR) systems with community partners, comprehensive application managed services, and reliable public cloud-based backup and disaster recovery solutions. Its diverse client base spans healthcare providers, insurance carriers, pharmaceutical and life sciences firms, biotechnology companies, and medical device manufacturers. Established in 2019, Healthcare Triangle, Inc. operates out of Pleasanton, California, as a subsidiary of SecureKloud Technologies, Inc.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.78
+0.04 (+2.05%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
281.1K
Beta
1.05
Float Shares
121.0K
Free Float %
10.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.11% | -0.87% | -12.31% | -73.27% | -98.18% | -93.99% | -99.93% | -99.99% | -100.00% | -100.00% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (1 ratings, all time)
Buy
Price Targets & DCF
Current price
1.78
Ratings Trend (MoM)
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-1.05
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Healthcare Information Services: +14.2%+18.8% ★ Q1'26: +166.1% (vs Q1'25)
-
EPS growth Medical - Healthcare Information Services: +43.1%+99.1% ★ Q1'26: +99.9% (vs Q1'25)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%-132.1% Q1'26: -69.6% (vs Q1'25)
-
EBIT margin Medical - Healthcare Information Services: +8.8%-70.5% Q1'26: +0.0% (vs Q1'25)
-
ROIC Medical - Healthcare Information Services: +5.2%-75.0% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Medical - Healthcare Information Services: -0.1%+17,412.9% Q1'26: +263,323.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×-1.18× Q1'26: -0.10× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
35.27M
est: 40.00M (-11.8%)
|
45.89M
est: 47.00M (-2.4%)
|
33.20M
est: 55.90M (-40.6%)
|
11.70M
est: 61.30M (-80.9%)
|
13.89M
est: 16.86M (-17.6%)
|
24.42M
24.42M – 24.42M
+44.9% YoY
|
29.31M
29.31M – 29.31M
+20.0% YoY
|
| EBITDA |
-3.94M
est: -5.05M (+22.1%)
|
-10.70M
est: -5.94M (-80.2%)
|
-6.12M
est: -7.06M (+13.4%)
|
-3.86M
est: -18.54M (+79.2%)
|
-9.08M
est: -5.10M (-78.1%)
|
-7.39M
-7.39M – -7.39M
-44.9% YoY
|
-8.87M
-8.87M – -8.87M
-20.0% YoY
|
| EBIT |
-5.36M
est: -8.52M (+37.1%)
|
-13.64M
est: -10.01M (-36.3%)
|
-7.68M
est: -11.91M (+35.5%)
|
-4.74M
est: -21.96M (+78.4%)
|
-9.79M
est: -6.04M (-62.1%)
|
-8.75M
-8.75M – -8.75M
-44.9% YoY
|
-10.50M
-10.50M – -10.50M
-20.0% YoY
|
| Net Income |
-5.95M
est: 16.36M (-136.4%)
|
-14.36M
est: -10.56M (-36.0%)
|
-8.69M
est: -6.33M (-37.1%)
|
-5.97M
est: -831.96M (+99.3%)
|
-9.48M
est: -113.2K (-8,268.9%)
|
-32.8K
-32.8K – -32.8K
+71.0% YoY
|
-13.6K
-13.6K – -13.6K
+58.5% YoY
|
| SGA |
9.20M
est: 12.13M (-24.1%)
|
12.17M
est: 14.25M (-14.6%)
|
10.40M
est: 16.95M (-38.7%)
|
6.15M
est: 25.94M (-76.3%)
|
10.42M
est: 7.13M (+46.1%)
|
10.33M
10.33M – 10.33M
+44.9% YoY
|
12.40M
12.40M – 12.40M
+20.0% YoY
|
| EPS |
-30,207.00
est: 771.90 (-4,013.3%)
|
-57,998.00
est: -498.00 (-11,546.2%)
|
-31,051.00
est: -298.80 (-10,291.9%)
|
-16,895.00
est: -13,446.00 (-25.7%)
|
-153.15
est: -1.83 (-8,268.9%)
|
-0.53
-0.53 – -0.53
+71.0% YoY
|
-0.22
-0.22 – -0.22
+58.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-19.31M
OE per share TTM
-15,446.30
Owner's Yield
-910.09%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
0.2%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
5
Total invested
113.2K
Insider transactions (90d)
0
Beneficial owners (>5%)
1
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Technologies, Inc. | 25.50M | 63.29% | 25.50M | — | 25.50M | — | HC | USA | 2021-10-25 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
5
-6 vs prev Q
New positions
3
Closed positions
9
Increased
4
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | UBS GROUP AG | 40.7K +40.7K (+100.0%) | 109.5K +109.5K (+100.0%) | 65.80% +65.804 pp | 0.00% +0.000 pp | USD2.69 +0.0% | 1 qtrs NEW |
| 2 | BANK OF MONTREAL /CAN/ | 10.0K +10.0K (+100.0%) | 26.9K +26.9K (+100.0%) | 16.16% +16.162 pp | 0.00% +0.000 pp | USD2.69 +0.0% | 1 qtrs NEW |
| 3 | — | 859.00 +859.0 (+100.0%) | 2.3K +2.3K (+100.0%) | 1.39% +1.388 pp | 0.00% +0.000 pp | USD2.69 +0.0% | 1 qtrs NEW |
| 4 | VANGUARD FIDUCIARY TRUST CO | 482.00 +482.0 (+100.0%) | 1.3K +1.3K (+100.0%) | 0.78% +0.779 pp | 0.00% +0.000 pp | USD2.69 +0.0% | 1 qtrs NEW |
| 5 | BNP PARIBAS ARBITRAGE, SNC | 7.00 +7.0 (+100.0%) | 19.00 +19.0 (+100.0%) | 0.01% +0.011 pp | 0.00% +0.000 pp | USD2.57 +4.7% | 1 qtrs NEW |
| 6 | DANSKE BANK A/S | 1.00 +1.0 (+100.0%) | 3.00 +3.0 (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD2.00 +34.5% | 1 qtrs NEW |
| 7 | CITIGROUP INC | — -10.1K (-100.0%) | — -6.4K (-100.0%) | 0.00% -0.273 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 8 | VIRTU FINANCIAL LLC | — -26.8K (-100.0%) | — -17.0K (-100.0%) | 0.00% -0.722 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 2 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Invesco BuyBack Achievers ETF PKW | 0.00% | 2.3K | 0.62% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 2.2K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
3.00
Bullish
Ratio by volume
0.14
Bearish
Buys
3
Sells
1
Shares acquired
352.9K
Shares disposed
2.55M
Cash buys
—
Cash sales
—
Net activity
-2,197,064
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | SECUREKLOUD TECHNOLOGIES, INC. | 10% Owner | J-Other | D | Common Stock | 2,550,000 | 0.00 | — | 0 | D | ↗ |
| 2025-03-31 | Ramachandran Thyagarajan | Officer | J-Other | A | Common Stock | 14,627 | 0.00 | — | 29,627 | D | ↗ |
| 2025-03-31 | Kizhakevilayil Shibu | Director / Officer | J-Other | A | Common Stock | 34,129 | 0.00 | — | 54,129 | D | ↗ |
| 2025-03-31 | Kannappan Lakshmanan | Officer | J-Other | A | Common Stock | 304,180 | 0.00 | — | 324,180 | D | ↗ |
| 2024-03-12 | Rosa David A | Director | A-Award | A | Incentive Stock Option (Right To Buy) | 10,000 | 1.78 | 17.8K | 34,000 | — | ↗ |
| 2024-03-12 | McClurg Ronald W. | Director | A-Award | A | Incentive Stock Option (Right To Buy) | 5,000 | 1.78 | 8.9K | 10,000 | — | ↗ |
| 2024-03-12 | Bhuiyan Mohammad Jainal | Director | A-Award | A | Incentive Stock Option (Right To Buy) | 5,000 | 1.78 | 8.9K | 10,000 | — | ↗ |
| 2023-01-27 | Sookhoo Roy | Director | — | D | Common Stock | 0 | 0.00 | — | 75,757 | — | ↗ |
| 2023-01-27 | Rosa David A | Director | A-Award | A | Stock Option (Right to Buy) | 1 | 0.35 | 0.35 | 200,000 | — | ↗ |
| 2023-01-27 | McClurg Ronald W. | Director | — | D | Stock Option (Right to buy) | 50,000 | 0.39 | 19.7K | 0 | — | ↗ |
| 2023-01-27 | HEAPHY PAIGE | Director | — | D | Stock Option (Right to buy) | 50,000 | 0.39 | 19.7K | 0 | — | ↗ |
| 2023-01-27 | Bhuiyan Mohammad Jainal | Director | — | D | Stock Option (Right to buy) | 50,000 | 0.39 | 19.7K | 0 | — | ↗ |
| 2022-11-15 | Ramachandran Thyagarajan | Officer | D-Return | A | Common Stock | 100,000 | 0.19 | 19.0K | 100,000 | — | ↗ |
| 2022-11-09 | Ramachandran Thyagarajan | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-11-09 | Leo John C | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-08-19 | Rosa David A | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-08-19 | MATHIESEN JEFFREY S | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-08-19 | BJORNSTAD APRIL | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-03-31 | MATHIESEN JEFFREY S | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | VENKATACHARI SURESH | Director / Officer / 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | SUDISH MOGLI | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | Rosa David A | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | Ramachandran Thyagarajan | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | PRAKASH VIVEK | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | Leo John C | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | Kumar Anand | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | Kizhakevilayil Shibu | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | Kannappan Lakshmanan | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | GILL JAMES MICHAEL | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | GALLAGHER BRENDAN | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | BJORNSTAD APRIL | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-10-15 | VENKATACHARI SURESH | Director / Officer | — | D | SUPER VOTING PREFERRED STOCK | 0 | 0.00 | — | 6,000 | — | ↗ |
| 2021-10-15 | SUDISH MOGLI | Officer | — | D | Common Stock | 0 | 0.00 | — | 200,000 | — | ↗ |
| 2021-10-15 | SECUREKLOUD TECHNOLOGIES, INC. | 10% Owner | — | D | COMMON STOCK | 0 | 0.00 | — | 25,500,000 | — | ↗ |
| 2021-10-15 | Rosa David A | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-10-15 | Ramachandran Thyagarajan | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-10-15 | PRAKASH VIVEK | Director | — | D | Common Stock | 0 | 0.00 | — | 573,859 | — | ↗ |
| 2021-10-15 | Leo John C | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-10-15 | Kumar Anand | Officer | — | D | COMMON STOCK | 0 | 0.00 | — | 150,000 | — | ↗ |
| 2021-10-15 | Kizhakevilayil Shibu | Director | — | D | Common Stock | 0 | 0.00 | — | 200,000 | — | ↗ |
| 2021-10-15 | Kannappan Lakshmanan | Director | — | D | COMMON STOCK | 0 | 0.00 | — | 200,000 | — | ↗ |
| 2021-10-15 | GILL JAMES MICHAEL | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-10-15 | GALLAGHER BRENDAN | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-10-15 | BJORNSTAD APRIL | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-07-12 | VENKATACHARI SURESH | Officer | A-Award | A | Super Voting Preferred Stock | 6,000 | 0.00 | — | 6,000 | — | ↗ |
| 2021-01-13 | PRAKASH VIVEK | Director | — | D | Warrant (Right to buy) | 111,930 | 2.88 | 322.4K | 0 | — | ↗ |
| 2020-05-27 | Kannappan Lakshmanan | Director / Officer | D-Return | A | Common Stock | 200,000 | 0.00 | 200.00 | 200,000 | — | ↗ |
| 2020-05-08 | VENKATACHARI SURESH | Director / Officer / 10% Owner | A-Award | A | Common Stock | 25,500,000 | 0.30 | 7.65M | 25,500,000 | I | ↗ |
| 2020-04-27 | VENKATACHARI SURESH | Officer | A-Award | A | Common Stock | 25,500,000 | 0.30 | 7.65M | 25,500,000 | — | ↗ |
| 2020-04-27 | Kumar Anand | Officer | D-Return | A | Common Stock | 150,000 | 0.00 | 150.00 | 150,000 | — | ↗ |
| 2020-04-27 | Kizhakevilayil Shibu | Director | D-Return | A | Common Stock | 200,000 | 0.00 | 200.00 | 200,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-271.9K
Shares Outstanding
1.16M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| David Ayanoglou | Chief Financial Officer | 354.3K | male |
| Sujatha Ramesh | Principal Executive Officer (SEC), COO & Executive Director | 229.2K | female |
| Karen Hughes | Head of Practice of Meditech | — | female |
| Ceasar Cifuentes | Senior Director of Sales | — | male |
| Lisna Ismail | Head of Marketing, PR & Communications | — | female |
| Ronald Beteta | Head of Customer Success | — | — |
| Shelly Pierce | Head of Human Resources & Talent Acquisition | — | female |
| Lakshmanan Kannappan | Chief Information & Security Officer | — | male |
| Jason Mudrick | Head of Practice of Epic | — | male |
ESG Rating
ESG Score History MEDICAL - HEALTHCARE INFORMATION SERVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HCTI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
